The idea of vaccinating honeybees and shrimp would have sounded like science fiction only a few years ago. Both animals are invertebrates, lacking the sophisticated antibody-based immune systems that make vaccination possible in humans, dogs, cattle, and other vertebrates. Yet recent research has shown that even these seemingly simple creatures possess forms of immune memory that can be harnessed to protect them from disease. As a result, scientists have developed the world’s first licensed vaccine for an insect – the honeybee – and are now applying similar principles to shrimp aquaculture. These advances may transform two industries that are essential to the global food supply.
Honeybees were the first beneficiaries of this revolution. In January 2023, the U.S. Department of Agriculture granted a conditional license for a vaccine designed to protect honeybees against American foulbrood, a devastating bacterial disease caused by Paenibacillus larvae. American foulbrood is highly contagious and can destroy entire colonies. Traditionally, infected hives often had to be burned to prevent the disease from spreading.
Dalan Animal Health developed the honeybee vaccine, and it became the first vaccine ever approved for an insect species. Its method of delivery is ingenious. The process by which honeybees are vaccinated is remarkably different from the way vaccines are administered to mammals. Individual bees are not injected. Instead, the vaccine takes advantage of the natural feeding behavior within the hive. The vaccine contains inactivated fragments of Paenibacillus larvae, the bacterium that causes American foulbrood. These bacterial fragments are mixed into a food source that is consumed by nurse bees, the young worker bees responsible for caring for the queen and developing the brood.
After ingesting the vaccine material, the nurse bees process it as they produce royal jelly, the nutrient-rich secretion used to feed the queen. The bacterial fragments become incorporated into the royal jelly and are delivered to the queen as part of her normal diet. The queen, unaware of the process, consumes the royal jelly just as she would under natural conditions.
Once inside the queen’s body, the bacterial components are transported by a protein known as vitellogenin. This protein, long recognized as an important egg-yolk precursor in insects, serves an additional function by carrying bacterial molecules from the queen’s digestive tract into her developing eggs. As a result, the eggs contain information about the pathogen before they hatch.
This approach exploits a phenomenon known as transgenerational immune priming. For many years, scientists assumed that invertebrates possessed only a primitive innate immune system incapable of remembering previous infections. Research over the last two decades has shown that this assumption was incomplete. Although insects do not make antibodies, they can exhibit enhanced resistance to pathogens after prior exposure, and this protection can sometimes be passed from mother to offspring. The honeybee vaccine represents the first practical use of this discovery.
The significance of protecting honeybees extends far beyond beekeeping. Honeybees are among the world’s most important pollinators, contributing to the production of many fruits, vegetables, and nuts. Colony losses from disease, pesticides, habitat destruction, and environmental stress have become a major concern. A successful vaccination program could improve colony health and reduce economic losses for both beekeepers and farmers.
Encouraged by this success, researchers have turned their attention to shrimp. Shrimp farming is one of the world’s largest aquaculture industries, but it is constantly threatened by infectious diseases. Among the most destructive are White Spot Syndrome Virus (WSSV) and Early Mortality Syndrome (EMS), both capable of wiping out entire shrimp harvests and causing billions of dollars in losses.
For decades, many scientists believed that vaccination of shrimp would be impossible because crustaceans, like insects, lack antibodies and the adaptive immune system that underlies conventional vaccination. However, recent studies have shown that shrimp possess a form of “trained” innate immunity. Exposure to certain pathogen components can leave the immune system in a heightened state of readiness, improving survival when the animal later encounters the same disease.
Dalan Animal Health has reported promising results using technology inspired by its honeybee work. In proof-of-concept studies announced in 2025, vaccinated shrimp showed more than 60 percent protection against both White Spot Syndrome Virus and Early Mortality Syndrome. The company’s goal is to create practical vaccines that can be administered to large populations of shrimp without the need for individual injections.
Researchers are exploring several delivery methods. One of the most promising involves oral vaccines incorporated into feed. Studies published in 2025 demonstrated that specially engineered, heat-killed bacteria could deliver vaccine components into shrimp tissues, stimulate immune responses, and improve survival after viral challenge. Such methods are particularly attractive because shrimp are raised by the millions, making injection impractical.
The science behind shrimp vaccination is still developing, and no widely deployed commercial shrimp vaccine yet exists. Nevertheless, the progress is remarkable. What was once considered biologically impossible is now becoming a realistic disease-control strategy. Researchers increasingly view vaccination as a sustainable alternative to the heavy use of antibiotics and other chemical interventions in aquaculture.
The broader lesson from both honeybees and shrimp is that the immune systems of invertebrates are more sophisticated than scientists once believed. These animals may not possess antibodies, but they can nonetheless acquire a form of immune memory and pass protective effects to future generations. The honeybee vaccine has already demonstrated that this knowledge can be translated into practical agriculture. Shrimp vaccination may soon follow.
If these efforts succeed, they will represent a major advance in food production. Healthier honeybee colonies mean more reliable pollination of crops. Healthier shrimp mean more efficient and sustainable aquaculture. Together, these developments illustrate how modern immunology is expanding beyond traditional livestock and pets to encompass some of the smallest – but economically most important – animals on Earth.
